NEW YORK – The World Health Organization announced on Friday that its Medicines Patent Pool has sublicensed technology for rapid diagnostic testing to Nigeria’s Codix Bio.

The money will support the development of the firm's PidPort system for storage, viewing, sharing, and analysis of digital images of pathology slides.

The firm filed for Chapter 11 protection on Thursday and is seeking to sell its assets after facing turmoil in recent years.

April's clearances included respiratory disease assays, a Gram-negative infection test, and assays to aid the diagnosis and monitoring of thyroid disease.